| P50 | author | Mirta Schattner | Q120563604 |
| P2093 | author name string | Julia Etulain | |
| P2860 | cites work | Cloning of GMP-140, a granule membrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation | Q24292971 |
| | Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides | Q24298587 |
| | Endoglycan, a member of the CD34 family of sialomucins, is a ligand for the vascular selectins | Q24310535 |
| | Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors | Q24337334 |
| | P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo | Q24676512 |
| | Cell surface glypicans are low-affinity endostatin receptors | Q28187143 |
| | Galectins: regulators of acute and chronic inflammation | Q28272886 |
| | Platelets play an essential role in separating the blood and lymphatic vasculatures during embryonic angiogenesis | Q28509388 |
| | Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. | Q30090176 |
| | CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development. | Q30514065 |
| | Synthesis of thrombin-inhibiting heparin mimetics without side effects | Q30573078 |
| | Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin | Q31144359 |
| | Beyond thrombosis: the versatile platelet in critical illness | Q33394357 |
| | Galectins as modulators of tumour progression | Q34381235 |
| | Platelets enhance neutrophil transendothelial migration via P-selectin glycoprotein ligand-1. | Q34600458 |
| | Roles of heparan-sulphate glycosaminoglycans in cancer | Q34718195 |
| | P-selectin-mediated platelet adhesion promotes the metastasis of murine melanoma cells | Q35121768 |
| | Control of angiogenesis by galectins involves the release of platelet-derived proangiogenic factors | Q35161608 |
| | Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome | Q35483514 |
| | Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins | Q35810537 |
| | Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling | Q35883118 |
| | Interactions of platelets with subendothelium and endothelium | Q36090987 |
| | The origin and function of platelet glycosyltransferases | Q36106312 |
| | Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma | Q36340825 |
| | Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation | Q36361058 |
| | The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin | Q36375314 |
| | Effect of extracellular pH on selectin adhesion: theory and experiment | Q36554356 |
| | The vessel wall and its interactions | Q36677300 |
| | Role of platelet-endothelial cell adhesion molecule (PECAM) in platelet adhesion/aggregation over injured but not denuded endothelium in vivo and ex vivo | Q36797338 |
| | PECAM-1: a multi-functional molecule in inflammation and vascular biology | Q36943068 |
| | Platelets as cellular effectors of inflammation in vascular diseases | Q37081746 |
| | Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases | Q37307308 |
| | Endogenous galectins and the control of the host inflammatory response | Q37373062 |
| | ICAM-1 signaling in endothelial cells | Q37421151 |
| | Overlapping and distinct roles of Aspergillus fumigatus UDP-glucose 4-epimerases in galactose metabolism and the synthesis of galactose-containing cell wall polysaccharides. | Q37488408 |
| | Galectins in atherosclerotic disease | Q37652277 |
| | Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. | Q37700375 |
| | Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer | Q37736668 |
| | Platelets: pleiotropic roles in atherogenesis and atherothrombosis. | Q37776791 |
| | Platelets and the immune continuum | Q37857647 |
| | Serpin-glycosaminoglycan interactions. | Q37955392 |
| | Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer | Q37996614 |
| | Vascular galectins: regulators of tumor progression and targets for cancer therapy. | Q38128665 |
| | Galectin-1 and -9 in angiogenesis: a sweet couple. | Q38214807 |
| | Selectin inhibition: synthesis and evaluation of novel sialylated, sulfated and fucosylated oligosaccharides, including the major capping group of GlyCAM-1. | Q38348800 |
| | Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin. | Q39524033 |
| | Modulation of endothelial cell migration and angiogenesis: a novel function for the "tandem-repeat" lectin galectin-8. | Q39650835 |
| | Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas | Q39886779 |
| | Generation of platelet angiostatin mediated by urokinase plasminogen activator: effects on angiogenesis | Q40281259 |
| | Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions | Q40420958 |
| | Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. | Q40575096 |
| | The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells. | Q42003225 |
| | Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells | Q42211301 |
| | Galectin-8 elicits pro-inflammatory activities in the endothelium | Q42461134 |
| | Activated platelets induce secretion of interleukin-1beta, monocyte chemotactic protein-1, and macrophage inflammatory protein-1alpha and surface expression of intercellular adhesion molecule-1 on cultured endothelial cells | Q42679713 |
| | Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. | Q42773654 |
| | Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life. | Q42779021 |
| | Interaction of platelet factor 4 with fibroblast growth factor 2 is stabilised by heparan sulphate | Q42803468 |
| | Human platelets express and are activated by galectin-8. | Q42880920 |
| | Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha | Q42971426 |
| | Platelets take the lead in lymphatic separation | Q43591106 |
| | Role for sulfatides in platelet aggregation | Q43819754 |
| | Tumor cells secrete galectin-1 to enhance endothelial cell activity. | Q44132717 |
| | Cell biology. Beyond clotting: the powers of platelets | Q44781954 |
| | Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. | Q46653870 |
| | The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation | Q46913572 |
| | P-selectin and leukocyte microparticles are associated with venous thrombogenesis | Q47400180 |
| | Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege | Q47860342 |
| | P-selectin glycoprotein ligand-1 is expressed on endothelial cells and mediates monocyte adhesion to activated endothelium. | Q50335793 |
| | Platelet chemokines in health and disease. | Q50893679 |
| | Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. | Q52223671 |
| | Novel drug development opportunities for heparin. | Q54153135 |
| | Binding of galectin-1 to αIIbβ3 integrin triggers “outside-in” signals, stimulates platelet activation, and controls primary hemostasis | Q58855145 |
| P433 | issue | 12 | |
| P921 | main subject | endothelium | Q111140 |
| | glycobiology | Q899224 |
| P304 | page(s) | 1252-1259 | |
| P577 | publication date | 2014-06-13 | |
| P1433 | published in | Glycobiology | Q5572596 |
| P1476 | title | Glycobiology of platelet-endothelial cell interactions | |
| P478 | volume | 24 | |